Suraksha Diagnostic Limited
SURAKSHA.NS
National Stock Exchange of India291.25
INR
+1.00
- -
ISIN
INE877V01027
Return %
Stock
S&P500
1Y
-13.22
26.53
3Y
-30.31
76.60
5Y
-30.31
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Ritu Mittal
- Full Time Employees
- 1,175
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- Plot No. DG-12/1, Action Area 1D, Premises No. 02-0327, New Town, Rajarhat Kolkata India 700156
- IPO Date
- Dec 6, 2024
- Website
- surakshanet.com
- Similar Companies
- Business
- Suraksha Diagnostic Limited operates as an integrated diagnostic services provider offering comprehensive pathology, radiology, and medical consultation services across eastern India. The company delivers over 2,300 tests encompassing routine and specialized pathology including biochemistry, hematology, histopathology, molecular biology, cytogenetics, and next-generation sequencing; advanced radiology such as X-rays, ultrasonography, CT scans, MRI, and specialized imaging; cardiology tests like electrocardiograms, echocardiograms, stress tests, and Holter monitoring; gastroenterology procedures including endoscopies and colonoscopies; as well as neurology, dental, physiotherapy, immunology, rheumatology, eye care, fetal care, ENT, and specialty clinic consultations through its polyclinics with over 1,000 doctors. It maintains a hub-and-spoke model featuring a flagship 40,000 square foot central reference laboratory in New Town, Kolkata equipped with AI-enabled robotic tracks, liquid chromatography, and mass spectroscopy; eight satellite laboratories; 49 diagnostic centers comprising 13 hub centers, 11 medium centers, 23 small centers, and two public-private partnership centers; and 166 sample collection centers primarily in West Bengal, Bihar, Assam, Meghalaya, and Delhi NCR, supported by home collection, house calls, and digital report delivery. Founded in 1992 and headquartered in Kolkata, West Bengal, Suraksha Diagnostic employs approximately 1,175 staff and utilizes equipment from leading vendors including Siemens Healthineers, Wipro GE Healthcare, Roche Diagnostics, and Beckman Coulter. Recent developments include the April 2025 acquisition of a 63% stake in Fetomat Wellness Private Limited for maternal-fetal medicine and genomic integration; the launch of Suraksha Genomics in Q1 FY26 for advanced genetic and molecular testing; addition of 11 centers in H1 FY26 with plans for three more hub and six spoke centers; a December 2024 IPO raising Rs 846.25 crore for expansion; and subsidiaries such as Suraksha Radiology Private Limited and Asian Institute of Immunology and Rheumatology LLP.